These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14668810)

  • 1. Ace revisited: a new target for structure-based drug design.
    Acharya KR; Sturrock ED; Riordan JF; Ehlers MR
    Nat Rev Drug Discov; 2003 Nov; 2(11):891-902. PubMed ID: 14668810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposing ACE up the sleeve...
    Chandrashekhar Y; Narula J
    J Nucl Med; 2007 Feb; 48(2):173-4. PubMed ID: 17268010
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
    Hanif K; Bid HK; Konwar R
    Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme: its molecular function, new ACE inhibitors and future prospect].
    Shionoiri H; Sugimoto K; Takasaki I; Yasuda G
    Nihon Rinsho; 1992 Apr; 50 Suppl():743-52. PubMed ID: 1321923
    [No Abstract]   [Full Text] [Related]  

  • 5. A computational approach to the study of the binding mode of dual ACE/NEP inhibitors.
    Dimitropoulos N; Papakyriakou A; Dalkas GA; Sturrock ED; Spyroulias GA
    J Chem Inf Model; 2010 Mar; 50(3):388-96. PubMed ID: 20170101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure based drug design of angiotensin-I converting enzyme inhibitors.
    Anthony CS; Masuyer G; Sturrock ED; Acharya KR
    Curr Med Chem; 2012; 19(6):845-55. PubMed ID: 22214449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential.
    Unger T; Gohlke P
    Cardiovasc Res; 1994 Feb; 28(2):146-58. PubMed ID: 8143294
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
    Gensini GF; Lippi D; Conti AA
    Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of association between angiotensin I-converting enzyme (ACE) DD genotype and the frequency of ACE inhibitor therapy.
    Sigusch HH; Surber R; Vogt S; Müller S; Hoffmann A
    Pharmazie; 1997 Jul; 52(7):565-6. PubMed ID: 9266596
    [No Abstract]   [Full Text] [Related]  

  • 12. ACE inhibitory peptides derived from aquatic protein.
    Lin L; Lv S; Zhang X; Lu J; Ye Y; Jiang S
    Curr Protein Pept Sci; 2013 May; 14(3):235-41. PubMed ID: 23721314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.
    Manoharan S; Shuib AS; Abdullah N
    Afr J Tradit Complement Altern Med; 2017; 14(2):383-406. PubMed ID: 28573254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
    Natesh R; Schwager SL; Sturrock ED; Acharya KR
    Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should we play our hand when holding an ACE?
    Beattie WS
    Can J Anaesth; 2010 Aug; 57(8):720-4. PubMed ID: 20512539
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report.
    Dzau VJ; Bernstein K; Celermajer D; Cohen J; Dahlöf B; Deanfield J; Diez J; Drexler H; Ferrari R; Van Gilst W; Hansson L; Hornig B; Husain A; Johnston C; Lazar H; Lonn E; Lüscher T; Mancini J; Mimran A; Pepine C; Rabelink T; Remme W; Ruilope L; Ruzicka M; Schunkert H; Swedberg K; Unger T; Vaughan D; Weber M
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):149-60. PubMed ID: 12090908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme.
    FitzGerald RJ; Meisel H
    Br J Nutr; 2000 Nov; 84 Suppl 1():S33-7. PubMed ID: 11242444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [involvement of chymase in pathogenesis of cardiovascular diseases].
    Urata H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions among ACE, kinins and NO.
    Linz W; Wohlfart P; Schölkens BA; Malinski T; Wiemer G
    Cardiovasc Res; 1999 Aug; 43(3):549-61. PubMed ID: 10690327
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diversity in mechanism of angiotensin II production and application of the suppressive agents].
    Miyazaki T
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.